Who should be eligible for gene therapy clinical trials in red blood cell pyruvate kinase deficiency (PKD)?: Toward an expanded definition of severe PKD.

ABSTRACT:

SUBMITTER: Schwartz JD 

PROVIDER: S-EPMC9305868 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature